Ondansetron Injection 8mg/4ml
-
Product is not available
Country Of Origin : India
Ondansetron Injection
Ondansetron Injection is a biocompatible parenteral formulation designed for antiemetic therapy, providing precise 8mg/4ml dosing for rapid onset of action in clinical settings.
The 4ml standardized volume ensures repeatable dosing and consistent therapeutic effect.
Key Features:
- Optimized aqueous injectable for rapid systemic absorption
- 8mg active concentration per 4ml unit
- Maintains stability under ambient and refrigerated storage
- Minimized injection site irritation via controlled pH
Attributes:
- 8mg/4ml for predictable therapeutic efficacy
- Injectable formulation with controlled viscosity
- Regulatory-compliant for professional institutional use
Composition and Formulation Details
Ondansetron Injection contains pharmaceutically pure Ondansetron hydrochloride in sterile isotonic aqueous solution. Buffering agents maintain pH stability and active potency, while stabilizers prevent degradation, ensuring uniform dispersion and precise dosing upon administration.
Functional Characteristics and Performance
The formulation provides predictable pharmacokinetics and rapid therapeutic onset. Low-viscosity design facilitates smooth intravenous or intramuscular delivery. Chemical and physical stability is maintained under ambient and refrigerated conditions, enabling reliable performance in institutional settings.
Application and Industry Relevance
Ondansetron Injection is suitable for hospitals, clinics, and institutional buyers requiring bulk or OEM supply. Its regulated pharmaceutical status and export-ready packaging support professional B2B procurement, ensuring consistent antiemetic therapy for clinical and institutional use.
